Enhancing Developmental Motor Plasticity After Perinatal Stroke With Transcranial Direct Current Stimulation
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 23
- 试验地点
- 2
- 主要终点
- Change from baseline in the Assisting Hand Assessment (AHA) at 8 weeks
研究概览
简要总结
The purpose of this study is to test tDCS (transcranial direct current stimulation), a type of non-invasive brain stimulation, to determine whether it can improve motor function in children with perinatal stroke and hemiparesis. Children 6-18 years with imaging-confirmed perinatal stroke and functional motor impairment will be recruited. Children will be randomized (1:1) to receive sham or tDCS (20 minutes daily) during daily intensive, goal-directed motor learning therapy (90 minutes). Motor outcomes will be repeated at baseline, 1 week, and 2 months.
Aim 1: Establish the ability of tDCS to safely enhance motor learning in children with perinatal stroke.
Hypothesis 1: tDCS is safe and well tolerated in children.
Hypothesis 2: Contralesional, cathodal tDCS increases motor functional gains measured by AHA at 2 months in children with perinatal stroke.
详细描述
Methods details not included elsewhere
Study: Randomized, sham-controlled, double blind, phase II clinical trial.
Patient Population. All children will be recruited through the Alberta Perinatal Stroke Project (APSP); a large population-based perinatal stroke research cohort based at Alberta Children's Hospital and directed by the PI. Prospective APSP ascertainment since 2007 is combined with retrospective enrolment (1992-2007) with comprehensive International Classification of Disease codes (ICD-9, ICD-10)237 and institutional databases. These are fully characterized patients with confirmed diagnosis by modern neuroimaging assessed in person in standardized APSP clinics. Recruitment will occur randomly from the population of all children meeting the criteria below.
Inclusion/exclusion criteria - see below
Data Collection and Management. Candidate APSP families will be contacted with review of consent/assent forms. Families residing outside Calgary will have equal opportunity to participate through existing APSP support systems. All complimentary data from existing studies is extractable from the APSP database (demographics, imaging, risk factors, outcomes).13 Neuroimaging data will be managed through the ACH Pediatric Neuroimaging Laboratory according to institutional protocols. Neurophysiology data will be collected at the ACH Pediatric TMS Laboratory and securely stored centrally.107 The institutional Clinical Research Unit is a database management unit designed for clinical research and currently houses all APSP studies and trials. The research database platform encompasses data capture utilities, management tools, and security measures (Health Canada-compliant). Methods will adhere to the CONSORT guidelines and the study will be registered prior to consent of the first patient (www.clinicaltrials.gov).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- Triple (Participant, Care Provider, Outcomes Assessor)
入排标准
- 年龄范围
- 6 Years 至 18 Years(Child, Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Symptomatic hemiparetic CP (Pediatric Stroke Outcome Measure (PSOM) >0.5) AND Manual Abilities Classification System (MACS) grade I-IV AND child/parent perceived limitations
- •Clinical and MRI-confirmed perinatal stroke syndrome (NAIS, APPIS, PVI)
- •Active wrist extension >20 degrees, finger extension >10 degrees
- •Can lift the affected arm 15 cm above a table surface and grasp light objects
- •Term birth (>36 weeks) and current age 6 - 18 years
- •Informed consent
排除标准
- •Other neurological disorder not related to perinatal stroke
- •Multifocal perinatal stroke
- •Severe hemiparesis (no voluntary contraction in paretic hand, MACS level V)
- •Severe spasticity in the affected limb (Modified Ashworth Scale >3)
- •Severe developmental delay or other inability to comply with study protocol
- •Unstable epilepsy (>1 seizure/month or >2 medication changes last 6 months)
- •Any TMS or MRI contraindication including implanted electronic devices
- •Botox, orthopedic surgery, or other invasive therapy in past 12 months
- •Constraint, brain stimulation or other modulatory therapy in past 6 months
结局指标
主要结局
Change from baseline in the Assisting Hand Assessment (AHA) at 8 weeks
时间窗: 8 weeks
This is the established standard for the objective quantification of bilateral hand function in children with hemiparetic CP.This Rasch-built evaluation carries the strongest evidence of inter-rater, intra-rater, and test-retest reliabilities, test-validity, and responsiveness to change for bimanual tasks in children within our age range For more details about this measures please refer to the published literature.
次要结局
- tDCS Safety and Tolerability evaluation (TST)(Each day following the tDCS treatment (10x))
- Change from baseline in the Canadian Occupational Performance Measure (COPM) at 8 weeks(8 weeks)
- Change from baseline in the Canadian Occupational Performance Measure (COPM) at 1 week(Baseline, 1 week)
研究者
Adam Kirton
Associate Professor, Pediatrics and Clinical Neurosciences
University of Calgary
